|
Tim Illidge,MD,PhD1, Lena Specht,MD2, Joachim Yahalom,MD3,Berthe Aleman,MD,PhD4, Anne Kiil Berthelsen,MD5,Louis Constine,MD6,Bouthaina Dabaja,MD3, Kavita Dharmarajan,MD7,Andrea Ng,MD8,Umberto Ricardi,MD9, Andrew Wirth,MD10 |
|
|
1Institute of Cancer Sciences,University of Manchester,Manchester Academic Health Sciences Centre,The Christie National Health Service Foundation Trust,Manchester,United Kingdom; 2Department of Oncology and Hematology,Rigshospitalet,University of Copenhagen,Copenhagen,Denmark; 3Department of Radiation Oncology,Memorial Sloan-Kettering Cancer Center,New York,New York; 4Department of Radiotherapy,The Netherlands Cancer Institute,Amsterdam,The Netherlands; 5Department of Radiation Oncology and PET Centre,Rigshospitalet,University of Copenhagen,Copenhagen,Denmark; 6Departments of Radiation Oncology and Pediatrics,James P.Wilmot Cancer Center,University of Rochester Medical Center,Rochester,New York; 7Division of Radiation Oncology,Department of Radiation Oncology,The University of Texas MD Anderson Cancer Center,Houston,Texas; 8Department of Radiation Oncology,Brigham and Women’s Hospital and Dana-Farber Cancer Institute,Harvard University,Boston,Massachusetts; 9Radiation Oncology Unit,Department of Oncology,University of Torino,Torino,Italy; and 10Division of Radiation Oncology,Peter MacCallum Cancer Institute,St. Andrews Place,East Melbourne,AustraliaCui Jianxiong,Yang Yong,Qi Shunang,TranslationDepartment of Oncology,Sichuan Provincial Crops Hospital of Chinese People’s Armed Police Forces,Leshan 614000,China (Cui JX); 2Department of Radiation Oncology,National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing 100021,China (Yang Y,Qi SN) |
|
